UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy... Show more
a developer of electrotherapeutic devices
Industry MedicalNursingServices
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MUST | 20.31 | 0.09 | +0.45% |
| Columbia Multi-Sector Municipal Inc ETF | |||
| NBSM | 28.37 | -0.28 | -0.98% |
| Neuberger Small-Mid Cap ETF | |||
| GRID | 167.52 | -4.98 | -2.89% |
| First Trust NASDAQ® Cln Edge®StGidIfsETF | |||
| CHAI | 0.45 | -0.02 | -4.94% |
| Core AI Holdings Inc | |||
| HVAC | 32.51 | -2.09 | -6.04% |
| Advisorshares HVAC And Industrials ETF | |||
A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with CRL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To LIVN | 1D Price Change % | ||
|---|---|---|---|---|
| LIVN | 100% | -0.80% | ||
| CRL - LIVN | 48% Loosely correlated | -2.34% | ||
| NVST - LIVN | 42% Loosely correlated | +5.23% | ||
| ENOV - LIVN | 42% Loosely correlated | +2.51% | ||
| BVS - LIVN | 41% Loosely correlated | -0.68% | ||
| A - LIVN | 41% Loosely correlated | -0.17% | ||
More | ||||
| Ticker / NAME | Correlation To LIVN | 1D Price Change % |
|---|---|---|
| LIVN | 100% | -0.80% |
| Health Services category (243 stocks) | 1% Poorly correlated | +1.11% |
| Medical/Nursing Services category (138 stocks) | 0% Poorly correlated | +2.00% |
LIVN saw its Momentum Indicator move above the 0 level on July 28, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LIVN advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .
LIVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 162 cases where LIVN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for LIVN moved out of overbought territory on July 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Moving Average Convergence Divergence Histogram (MACD) for LIVN turned negative on July 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIVN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LIVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.694) is normal, around the industry mean (11.000). P/E Ratio (41.561) is within average values for comparable stocks, (63.941). Projected Growth (PEG Ratio) (0.899) is also within normal values, averaging (4.027). LIVN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.121) is also within normal values, averaging (29.285).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.